EP3215122
STABLE PROTEIN SOLUTION FORMULATION CONTAINING HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
6.11.2015:
13.8.2025:
15798609.2
:
5.11.2035:
12.12.2025
:
STABLE PROTEIN SOLUTION FORMULATION CONTAINING HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY
6.11.2015
13.8.2025
12.12.2025
:
Novartis AG:
Lichtstrasse 35, 4056 Basel, CH
:
ZHANG, Huixiang:
Fort Worth, Texas 76134, US
:
BORING, Charles:
Fort Worth, Texas 76134, US
:
KULSHRESHTHA, Alok:
Grapevine, Texas 76051, US
:
ZENG, Yuhong:
Fort Worth, Texas 76134, US
:
WAN, Li:
Fort Worth, Texas 76134, US
:
ALANI, Laman:
Fort Worth, Texas 76134, US
:
201462076770 P:
7.11.2014:
US
:
201462088061 P:
5.12.2014:
US
:
US2015059571:
6.11.2015
:
A61P 43/00, C07K 16/22, A61P 27/02, A61K 9/00, A61K 39/395